IRG1/ACOD1 promotes neutrophil reverse migration and alleviates local inflammation
Journal of Leukocyte Biology · 01.10.2024 · 116 (4) · 854-863
DOI: 10.1093/jleuko/qiae110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 07.05.2024. Verfasst von Jingjing Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh 15213, United States. Hauptthemen laut MEDLINE: Neutrophils, Carboxy-Lyases, Inflammation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: VA Merit Award, BLRD VA, NHLBI NIH HHS.
Abstract (Originalsprache)
Polymorphonuclear neutrophil (PMN) infiltration at inflammatory site plays a critical role in inflammation. PMN reverse migration (rM) describes the phenomenon that PMNs migrate away from inflammatory site back into the vasculature, and its role within inflammatory scenarios remains to be fully determined. This study aimed to investigate the mechanism underlying PMN rM and its role in inflammation. First, we demonstrated PMN rM in a mouse model of lipopolysaccharide-induced acute lung inflammation. By single-cell RNA sequencing, we demonstrated that reverse migrated (rM-ed) PMNs in blood expressed a high level of immune-responsive gene 1 (Irg1), the encoding gene of cis-aconitate decarboxylase (ACOD1). Using a mouse air pouch model, which enabled us to directly track rM-ed PMNs in vivo, we detected higher expression of ACOD1 in the rM-ed PMNs in circulation. Furthermore, mice with Irg1 knockout exhibited decreased PMN rM and higher levels of inflammatory cytokine in inflammatory site. Mechanistically, we found that itaconate, the product of ACOD1 catalyzation, decreased PMN ICAM-1 expression at the inflammation site. Furthermore, inflammatory site showed a high level of shed Cd11a, the ligand of ICAM-1. Neutralization of either ICAM-1 or Cd11a led to increased PMN rM. These findings suggest that the binding of ICAM-1 and shed Cd11a serves as a retaining force to hold PMNs in the site of inflammation, and ACOD1-decreased PMN surface expression of ICAM-1 weakens the retaining force, promoting PMNs to leave the inflammatory site. These results indicate a regulatory role of IRG1 in PMN rM and subsequent contributions to inflammation resolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh 15213, United States.
- McGowan Institute for Regenerative Medicine, University of Pittsburgh, 450 Technology Drive, Pittsburgh, PA 15219, United States.
- Research and Development, VA Pittsburgh Healthcare System, University Drive C, Pittsburgh, PA 15240, United States.
- Department of Immunology, University of Pittsburgh School of Medicine, 5051 Centre Avenue, Pittsburgh 15213, United States.
ORCID-Profile: Melanie J Scott
Förderung
- VA Merit Award
- BLRD VA
- NHLBI NIH HHS
- NIGMS NIH HHS
- VA BLR&D Research Career Scientist Award
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ji, J., Zhong, H., Li, Y., Billiar, T. R., Wilson, M. A., Scott, M. J., & Fan, J. (2024). IRG1/ACOD1 promotes neutrophil reverse migration and alleviates local inflammation. Journal of Leukocyte Biology, 116(4), 854-863. https://doi.org/10.1093/jleuko/qiae110
Vancouver
Ji J, Zhong H, Li Y, Billiar TR, Wilson MA, Scott MJ, et al. IRG1/ACOD1 promotes neutrophil reverse migration and alleviates local inflammation. Journal of Leukocyte Biology. 2024;116(4):854-863. doi:10.1093/jleuko/qiae110
BibTeX
@article{Ji2024,
author = {Ji, Jingjing and Zhong, Hanhui and Li, Yuehua and Billiar, Timothy R and Wilson, Mark A and Scott, Melanie J and Fan, Jie},
title = {IRG1/ACOD1 promotes neutrophil reverse migration and alleviates local inflammation},
journal = {Journal of Leukocyte Biology},
year = {2024},
volume = {116},
number = {4},
pages = {854--863},
doi = {10.1093/jleuko/qiae110}
}
EUVIMED